Literature DB >> 28960925

Surgery for constipation: systematic review and clinical guidance: Paper 1: Introduction & Methods.

C H Knowles1, U Grossi1, E J Horrocks1, D Pares2, P F Vollebregt1, M Chapman3, S R Brown4, M Mercer-Jones5, A B Williams6, R J Hooper7, N Stevens7, J Mason8.   

Abstract

AIM: This manuscript provides the introduction and detailed methodology used in subsequent reviews to assess the outcomes of surgical interventions with the primary intent of treating chronic constipation in adults and to develop recommendations for practice.
METHOD: PRISMA guidance was adhered to throughout. A literature search was performed in public databases between January 1960 and February 2016. Studies that fulfilled strictly-defined PICOS (patients, interventions, controls, outcome, and study design) criteria were included. The process involved two groups of participants: (i): 'a clinical guidance group' of 18 UK experts (including junior support) who performed the systematic reviews and produced summary evidence statements (SES) based strictly on data synthesis in each review. The same group then produced prototype graded practice recommendations (GPRs) based on coalescence of SES and expert opinion; (ii): a European Consensus group of 18 ESCP (European Society of Coloproctology) nominated experts from nine European countries evaluated the appropriateness of each prototype GPR based on published RAND/UCLA methodology.
RESULTS: An overview of the search results is provided in this manuscript. A total of 156 studies from 307 full text articles (from 2551 initially screened records) were included, providing data on procedures characterized by: (i) colonic resection (n = 40); (ii) rectal suspension (n = 18); (iii) rectal wall excision (n = 44); (iv) rectovaginal septum reinforcement (n = 47); (v) sacral nerve stimulation (n = 7). The overall quality of evidence was poor with 113/156 (72.4%) studies providing only Oxford level IV evidence. The best evidence was extracted for rectal excisional procedures, where the majority of studies were Oxford level I or II. The five subsequent reviews provide a total of 99 SES (reflecting perioperative variables, efficacy, harms and prognostic variables) that contributed to 100 prototype GPRs covering patient selection, procedural considerations and patient counselling. The final manuscript details the 85/100 GPRs that were deemed appropriate by European Consensus (remaining 15 were all uncertain) and future research recommendations.
CONCLUSION: This manuscript and the following 6 papers suggest that the evidence base for surgical management of chronic constipation is currently poor although some expert consensus exists on best practice. Further studies are required to inform future commissioning of treatments and of research funding.
© 2017 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Constipation; obstructed defaecation; surgery

Mesh:

Year:  2017        PMID: 28960925     DOI: 10.1111/codi.13774

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  3 in total

1.  Recalled stapler device, high complication rate, non validated scoring system and misquote from the STARR surgeons.

Authors:  U Grossi; M Mercer-Jones; G L Di Tanna; C H Knowles
Journal:  Tech Coloproctol       Date:  2019-08-26       Impact factor: 3.781

2.  Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation.

Authors:  Yadong Fan; Chen Xu; Lulu Xie; Ying Wang; Shan Zhu; Jiren An; Yuwei Li; Zhikui Tian; Yiqi Yan; Shuang Yu; Haizhao Liu; Beitian Jia; Yiyang Wang; Li Wang; Long Yang; Yuhong Bian
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

3.  microRNA overexpression in slow transit constipation leads to reduced NaV1.5 current and altered smooth muscle contractility.

Authors:  Amelia Mazzone; Peter R Strege; Simon J Gibbons; Constanza Alcaino; Vikram Joshi; Andrew J Haak; Daniel J Tschumperlin; Cheryl E Bernard; Robert R Cima; David W Larson; Heidi K Chua; Rondell P Graham; Mona El Refaey; Peter J Mohler; Yujiro Hayashi; Tamas Ordog; Stefan Calder; Peng Du; Gianrico Farrugia; Arthur Beyder
Journal:  Gut       Date:  2019-11-22       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.